STAQ Pharma, Inc. is recalling 2,616 bags of Ropivacaine HCl 0.2% PF in Sodium Chloride (1,000 mg/500 mL) Injection. This recall was initiated after reports of leaking bags and structural concerns caused by a manufacturing defect at the bag supplier's facility. While no injuries have been reported, a leaking bag can compromise the sterility of the medication or result in an incorrect dose being administered to a patient. Hospitals and clinics should immediately identify and stop using any affected bags from the nine specific lots included in this recall.
Leaking bags can lead to a loss of product sterility or an incomplete dosage being delivered to patients. This defect could potentially cause infections or treatment failure in clinical settings.
The source of the issue was bag manufacturer Lot # 134142-001A which failed internal quality control tests for leaks.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.